Skip to the page

Data / Drug companies / Professional Compounding Centers of America DBA Pcca

Professional Compounding Centers of America DBA Pcca: 487 products in the FDA NDC directory, labeler code 51927

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Professional Compounding Centers of America DBA Pcca (labeler code 51927) lists 487 products in the FDA National Drug Code Directory. By type: 487 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on October 23, 2026.

The request: Watch Professional Compounding Centers of America DBA Pcca (FDA labeler code 51927): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
51927
Products in commercial distribution
487
Packages
487
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule II 16, Schedule III 18, Schedule IV 14, Schedule V 1
Started marketing in the last 12 months
20
Products with a marketing end date set
27
Earliest marketing start
May 1, 1996
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding487100%

Products by type

TypeProductsShare
Bulk ingredients487100%

Dosage forms

Dosage formProductsShare
Powder47697.7%
Liquid30.6%
Crystal30.6%
Concentrate20.4%
Powder, for suspension10.2%
Solution10.2%
Granule10.2%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ibuprofen51927-0392PowderBulk ingredients for compoundingOctober 23, 2026
Nifedipine51927-0391PowderBulk ingredients for compoundingAugust 20, 2026
Progesterone51927-0389PowderBulk ingredients for compoundingJune 19, 2026
Azelaic acid51927-0390PowderBulk ingredients for compoundingJune 17, 2026
Miconazole nitrate51927-0388PowderBulk ingredients for compoundingMay 27, 2026
Haloperidol51927-0387PowderBulk ingredients for compoundingMarch 31, 2026
Ondansetron hydrochloride51927-0386PowderBulk ingredients for compoundingFebruary 25, 2026
Propofol51927-4503LiquidBulk ingredients for compoundingFebruary 17, 2026
Ondansetron hydrochloride51927-0385PowderBulk ingredients for compoundingFebruary 17, 2026
Mercaptopurine51927-4500PowderBulk ingredients for compoundingFebruary 5, 2026
Propofol51927-5296PowderBulk ingredients for compoundingJanuary 30, 2026
Lorazepam51927-0384PowderBulk ingredients for compoundingJanuary 30, 2026
Neomycin sulfate51927-0383PowderBulk ingredients for compoundingJanuary 29, 2026
Dexamethasone51927-0382PowderBulk ingredients for compoundingJanuary 27, 2026
Phytonadione51927-5292PowderBulk ingredients for compoundingDecember 18, 2025
Heparin sodium51927-0381PowderBulk ingredients for compoundingDecember 9, 2025
Dexamethasone sodium phosphate51927-0380PowderBulk ingredients for compoundingDecember 2, 2025
Morphine sulfate51927-0379PowderBulk ingredients for compoundingDecember 1, 2025
Linezolid51927-5293PowderBulk ingredients for compoundingNovember 21, 2025
Ergocalciferol51927-5291PowderBulk ingredients for compoundingNovember 19, 2025
Gabapentin51927-0378PowderBulk ingredients for compoundingOctober 23, 2025
Chlorhexidine gluconate51927-0377SolutionBulk ingredients for compoundingOctober 22, 2025
Celecoxib51927-0376PowderBulk ingredients for compoundingOctober 8, 2025
Tetracaine hydrochloride51927-0374PowderBulk ingredients for compoundingSeptember 4, 2025
Voriconazole51927-5286PowderBulk ingredients for compoundingSeptember 3, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.